alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
<PAGE>
                                  EXHIBIT 99(b)

                 Chief Financial Officer Certification Pursuant
                to Section 906 of the Sarbanes-Oxley Act of 2002

<PAGE>
                            CERTIFICATION PURSUANT TO
                             18 U.S.C. SECTION 1350,
                                   AS ADDED BY
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

        In connection with the Annual Report of First Southern Bancshares, Inc.
(the "Company") on Form 10-KSB for the fiscal year ended December 31, 2002 as
filed with the Securities and Exchange Commission (the "Report"), I, Roderick V.
Schlosser, Executive Vice President and Chief Financial Officer of the Company,
certify, pursuant to 18 U.S.C. ss.1350, as added by Section 906 of the
Sarbanes-Oxley Act of 2002, that:

        (1) The Report fully complies with the requirements of Section 13(a) or
            15(d) of the Securities Exchange Act of 1934; and

        (2) The information contained in the Report fairly presents, in all
            material respects, the financial condition and results of operations
            of the Company as of and for the period covered by the Report.

                                         /s/ Roderick V. Schlosser
                                         -------------------------------------
                                         Roderick V. Schlosser
                                         Executive Vice President
                                         and Chief Financial Officer

Date: April 15, 2003

A signed original of this written statement required by Section 906 has been
provided to First Southern Bancshares, Inc. and will be retained by First
Southern Bancshares, Inc. and furnished to the Securities and Exchange
Commission or its staff upon request.
Sandra Lee CALKINS, petitioner, v. UNITED STATES.

No. 15-9313.

Supreme Court of the United States

Nov. 14, 2016.

Petition for writ of certiorari to the United States Court of Appeals for the Eighth Circuit denied.
Supplement to the


Fidelity® Total International Equity Fund


Class A, Class M, Class C, Class I, and Class Z


December 30, 2024


Summary Prospectus












The following information supplements information found in the "Fund Summary" section under the "Portfolio Manager(s)" heading.


Ryan Oldham (Co-Portfolio Manager) has managed the fund since 2025.


ATIE-SUSTK-0225-1051.9881413.105February 3, 2025


Supplement to the


Fidelity® Total International Equity Fund


December 30, 2024


Summary Prospectus












The following information supplements information found in the "Fund Summary" section under the "Portfolio Manager(s)" heading.


Ryan Oldham (Co-Portfolio Manager) has managed the fund since 2025.


TIE-SUSTK-0225-1021.9886610.102February 3, 2025
```

[Congressional Bills 111th Congress]
[From the U.S. Government Publishing Office]
[H. Res. 1737 Reported in House (RH)]

                                                 House Calendar No. 246
111th CONGRESS
  2d Session
H. RES. 1737

                          [Report No. 111-661]

     In the matter of Representative Charles B. Rangel of New York.

_______________________________________________________________________

                    IN THE HOUSE OF REPRESENTATIVES

                           November 29, 2010

   Ms. Zoe Lofgren of California, from the Committee on Standards of 
Official Conduct, reported the following resolution; which was referred 
            to the House Calendar and ordered to be printed

_______________________________________________________________________

                               RESOLUTION

 
     In the matter of Representative Charles B. Rangel of New York.

    Resolved, That (1) Representative Charles B. Rangel of New York be 
censured; (2) Representative Charles B. Rangel forthwith present 
himself in the well of the House for the pronouncement of censure; (3) 
Representative Charles B. Rangel be censured with the public reading of 
this resolution by the Speaker; and (4) Representative Rangel pay 
restitution to the appropriate taxing authorities or the U.S. Treasury 
for any unpaid estimated taxes outlined in Exhibit 066 on income 
received from his property in the Dominican Republic and provide proof 
of payment to the Committee.
                                                 House Calendar No. 246

111th CONGRESS

  2d Session

                              H. RES. 1737

                          [Report No. 111-661]

_______________________________________________________________________

                               RESOLUTION

     In the matter of Representative Charles B. Rangel of New York.

_______________________________________________________________________

                           November 29, 2010

        Referred to the House Calendar and ordered to be printed
```
No. 720.

#### Thys et al., doing business as Thys & Miller, *v.*State of Washington.

Supreme Court of Washington.

*Elwood Hutcheson*and *George W. Wilkins*for petitioners.

*Smith Troy,*Attorney General of Washington, for respondent.

Certiorari denied.
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Federal Reserve System

# AGENCY HOLDING THE MEETING:

Board of Governors of the Federal Reserve System. 

# TIME AND DATE:

12:00 noon, Monday, June 25, 2001. 

# PLACE:

Marriner S. Eccles Federal Reserve Board Building, 20th and C Streets, NW., Washington, DC 20551. 

# STATUS:

Closed. 

# MATTERS TO BE CONSIDERED:

 

1. Personnel actions (appointments, promotions, assignments, reassignments, and salary actions) involving individual Federal Reserve System employees. 

2. Any items carried forward from a previously announced meeting. 

# CONTACT PERSON FOR MORE INFORMATION:

Michelle A. Smith, Assistant to the Board; 202-452-3204. 

# SUPPLEMENTARY INFORMATION:

You may call 202-452-3206 beginning at approximately 5 p.m. two business days before the meeting for a recorded announcement of bank and bank holding company applications scheduled for the meeting; or you may contact the Board's Web site at http://www.federalreserve.gov for an electronic announcement that not only lists applications, but also indicates procedural and other information about the meeting. 

Dated: June 15, 2001. 

Robert deV. Frierson, 

Associate Secretary of the Board. 

[FR Doc. 01-15544 Filed 6-15-01; 2:08 pm] 

BILLING CODE 6210-01-P
ex10-2.htm


Exhibit 10.2

 

Marten Transport, Ltd.

2016 Non-Employee Director Compensation Summary 

 

On May 10, 2016, our Compensation Committee also approved the following fee schedule for non-employee directors for fiscal year 2016, which increases the annual retainer for non-employee directors from $26,000 to $30,000, but otherwise remains unchanged from the fee schedule for 2015:

 

	 	 	
2016
	 
	 	 	 	 	 
	
Annual Board Retainer
	 	$	30,000	 
	
Lead Director
	 	 	10,000	 
	
Audit Committee chair
	 	 	15,000	 
	
Compensation Committee chair
	 	 	10,000	 
	
Nominating/Corporate Governance Committee chair
	 	 	3,500	 


 

Non-employee directors also receive $1,500 for attendance at each Board meeting, $750 for each committee meeting attended and reimbursement for out-of-pocket expenses related to attending meetings.

 

Each non-employee director will also receive a grant of 1,000 shares of common stock in connection with re-election to the Board by the stockholders.
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Health and Human Services

###### National Institutes of Health

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting:

The meeting will be closed to the public in accordance with the  provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The contract proposals and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the contract proposals, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

*Name of Committee:*                         National Institute of Child Health and Human Development Special Emphasis Panel Workgroup.                    

*Date:*                         June 25, 2001.                    

*Time:*                         1 p.m. to 2:30 p.m.                    

*Agenda:*                         To review and evaluate contract proposals.                    

*Place:*                         6100 Executive Blvd., 5th Floor, Rockville, MD 20852, (Telephone Conference Call).                    

*Contact Person:*                         Hameed Khan, Scientific Review Administrator, Division of Scientific Review, National Institute of Child Health and Human Development, National Institutes of Health, 6100 Executive Blvd., Room 5E01, Bethesda, MD 20892, (301) 496-1485.                     

This notice is being published less than 15 days  prior to the meeting due to the timing limitations imposed by the review and funding cycle.

(Catalogue of Federal Domestic Assistance Program Nos. 93.209, Contraception and Infertility Loan Repayment Program; 93.864, Population Research; 93.865, Research for Mothers and Children; 93.929, Center for Medical Rehabilitation Research, National Institutes of Health, HHS)

Dated: June 18, 2001.

LaVerne Y. Stringfield,

Director, Office of Federal Advisory Committee Policy.

[FR Doc. 01-15759 Filed 6-21-01; 8:45 am]

BILLING CODE 4140-01-M
Exhibit 10.6


 


May 20, 2016


 


CB Pharma Acquisition Corp.


3 Columbus Circle, 15th Floor


New York, New York 10019


 


EarlyBirdCapital, Inc.


366 Madison Avenue, 8th Floor


New York, New York 10017


 


Gentlemen:


 


Based on the contemporaneous due execution and delivery of (i)
the Agreement dated as of even date herewith among certain Sellers (as specified therein), EJF Opportunities, LLC, Stephen B. Pudles,
Jose M. Aldeanueva, Jeffrey J. Gutovich Profit Sharing Plan and Barry Rodgers  (collectively, the “Investors”),
and CB Pharma Acquisition Corp. (“Company”) and (ii) the Insider Letters of the Investors, Edward J. Fred and
Jeffrey J. Gutovich, each substantially in the form provided to each of the undersigned, each of the undersigned individuals hereby
agrees that with regard to their respective letter agreements with the Company, dated December 12, 2014, the entire Section 12
is hereby deleted in its entirety. Additionally, upon approval of the matters set forth in Section 7.3 of the Agreement, Section
2(a) and the first sentence of Section 9 shall be deleted in their entirety.


 


[Remainder of page intentionally
left blank; signature page to follow.]


 




     


     


    

 


If the foregoing correctly sets forth our
agreement, please so confirm by signing below in the space indicated.


 


	/s/ Lindsay A. Rosenwald	 	/s/ Michael Weiss
	Lindsay A. Rosenwald	 	Michael Weiss
	 	 	 
	/s/ Adam J. Chill	 	/s/ Arthur A. Kornbluth
	Adam J. Chill	 	Arthur A. Kornbluth
	 	 	 
	/s/ Neil Herskowitz	 	/s/ George Avgerinos
	Neil Herskowitz	 	George Avgerinos
	 	 	 
	EARLYBIRDCAPITAL, INC.	 	CB PHARMA ACQUISITION CORP.
		 	 	 	 
	By:	/s/ David Nussbaum	 	By:	/s/ Lindsay A. Rosenwald
	Title:	Chairman	 	Title:	CEO


 


[Insider Letter Amendment - Officers and Directors]
<TABLE> <S> <C>

<ARTICLE> 9
<MULTIPLIER> 1,000
       
<S>                             <C>
<PERIOD-TYPE>                   YEAR
<FISCAL-YEAR-END>                          DEC-31-1998
<PERIOD-START>                             JAN-01-1998
<PERIOD-END>                               DEC-31-1998
<CASH>                                          13,229
<INT-BEARING-DEPOSITS>                             422
<FED-FUNDS-SOLD>                                 4,354
<TRADING-ASSETS>                                     0
<INVESTMENTS-HELD-FOR-SALE>                     18,028
<INVESTMENTS-CARRYING>                          30,297
<INVESTMENTS-MARKET>                            30,389
<LOANS>                                        207,835
<ALLOWANCE>                                      2,193
<TOTAL-ASSETS>                                 280,767
<DEPOSITS>                                     243,858
<SHORT-TERM>                                    10,398
<LIABILITIES-OTHER>                              1,537
<LONG-TERM>                                        526
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                         2,972
<OTHER-SE>                                      21,476
<TOTAL-LIABILITIES-AND-EQUITY>                 280,767
<INTEREST-LOAN>                                 17,864
<INTEREST-INVEST>                                1,955
<INTEREST-OTHER>                                   484
<INTEREST-TOTAL>                                20,303
<INTEREST-DEPOSIT>                               9,283
<INTEREST-EXPENSE>                               9,912
<INTEREST-INCOME-NET>                           10,391
<LOAN-LOSSES>                                      585
<SECURITIES-GAINS>                                   0
<EXPENSE-OTHER>                                  6,095
<INCOME-PRETAX>                                  6,013
<INCOME-PRE-EXTRAORDINARY>                       6,013
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                     4,066
<EPS-PRIMARY>                                    $1.16
<EPS-DILUTED>                                    $1.16
<YIELD-ACTUAL>                                    8.62
<LOANS-NON>                                        170
<LOANS-PAST>                                       190
<LOANS-TROUBLED>                                     0
<LOANS-PROBLEM>                                      0
<ALLOWANCE-OPEN>                                 2,078
<CHARGE-OFFS>                                      497
<RECOVERIES>                                        27
<ALLOWANCE-CLOSE>                                2,193
<ALLOWANCE-DOMESTIC>                             2,193
<ALLOWANCE-FOREIGN>                                  0
<ALLOWANCE-UNALLOCATED>                              0
        

</TABLE>
WASHINGTON, petitioner, v. Mathew Wilson MOI.

No. 15-951.

Supreme Court of the United States

Dec. 5, 2016.

Motion of respondent for leave to proceed *in forma pauperis* granted. Petition for writ of certiorari to the Supreme Court of Washington denied.
ERGUR PRIVATE EQUITY GROUP, LLC, petitioner, v. Gary CATRON.

No. 16-542.

Supreme Court of the United States

Jan. 9, 2017.

Petition for writ of certiorari to the Court of Appeals of Ohio, Lucas County denied.
Darla Ray JONES, petitioner, v. CALIFORNIA.

No. 16-5180.

Supreme Court of the United States

Nov. 14, 2016.

Petition for rehearing denied.
<PAGE>












                                  Exhibit 23(a)

             Consent of Kraft Bros., Esstman, Patton & Harrell, PLLC















<PAGE>




                          INDEPENDENT AUDITORS' CONSENT

         We consent to the incorporation by reference in First Southern
Bancshares, Inc.'s Registration Statement No. 333-03832 on Form S-8 and in First
Southern Bancshares, Inc.'s Registration Statement No. 333-32619 on Form S-8 of
our report dated February 28, 2003, for the year ended December 31, 2001
appearing in this Form 10-KSB/A.


/s/ KRAFT BROS., ESSTMAN, PATTON & HARRELL, PLLC



Nashville, Tennessee
April 14, 2003
877.

#### Wilcox *v.*Sargeant.

Russell, J.

1. The fact that the evidence would have authorized a larger recovery in behalf of the prevailing party in a case than the amount of the verdict affords no ground of complaint to his adversary. *Gilmore*v. *Taylor, 3 Ga. App.*93 (59 S. E. 325); *Ellis*v. *U. S. Fert. Co.,*64 *Ga.*571.

2. The rule that parol evidence is inadmissible to vary the terms of a written contract is not violated by the admission of parol testimony to the effect that a certain payment was made upon a different purchase than that mentioned in the bond for title.

3. There was no error in refusing a new trial, where the controlling issue of fact (as to whether a payment, alleged to have been made by the plaintiff, was a penalty or a forfeiture, or a partial payment on a purchase) was fairly submitted to the jury, and where evidence was submitted showing that it was a payment on a contract of sale which the defendant had failed to carry out, as well as evidence that it was a payment on a different transaction, in which the defendant had complied with all of his obligations. - *Judgment affirmed.*

*36Appeal, from Wilcox superior court — Judge Whipple. November 9, 1907.

Submitted September 4, 1907,

Decided March 16, 1908.

*Hal Lawson,*for plaintiff in error.

*Max M. Land, Walter F. Hall,*contra.
**EXHIBIT 32.1**

CERTIFICATIONPURSUANT TO 18 U.S.C. SECTION 1350 AS ADOPTED PURSUANT TO SECTION 906 OF THESARBANES-OXLEY ACT OF 2002

Inconnection with the Quarterly Report of Fulton Bancshares Corporation (the “Corporation”)on Form 10-Q for the period ending September 30, 2005 as filed with theSecurities and Exchange Commission on the date hereof (the “Report”), I, George W.Millward, Acting Chief Executive Officer of the Corporation, certify, pursuantto 18 U.S.C. section 1350, as adopted pursuant to section 906 of theSarbanes-Oxley Act of 2002, that:

(1)The Report fully complies with the requirements of Section 13(a) or 15(d) ofthe Securities Exchange Act of 1934; and

(2)The information contained in the Report fairly presents, in all materialrespects, the financial condition and results of operations of the Corporation.
| Date: November 14, 2005 | By:                                           | /s/George W. Millward |
|-------------------------|-----------------------------------------------|-----------------------|
|                    | George W. Millward,                           |
|                    | Interim President and Chief Executive Officer |

 

----
IV 

111TH CONGRESS 

2D SESSION H. RES. 1659 

Designating Robert V. Remini as Historian Emeritus of the United States 

House of Representatives. 

IN THE HOUSE OF REPRESENTATIVES 

SEPTEMBER 23, 2010 

Mr. LARSON of Connecticut (for himself and Mr. KIRK) submitted the following resolution; which was referred to the Committee on House Administration 

RESOLUTION 

Designating Robert V. Remini as Historian Emeritus of the 

United States House of Representatives. 

Whereas Robert V. Remini retired from the United States 

House of Representatives after serving with distinction as 

the Historian of the House from 2005 to 2010; 

Whereas Robert V. Remini has dedicated his House service 

to preserving, protecting, and promoting the history of 

the House of Representatives and its members; 

Whereas Robert V. Remini has produced or directed production of a number of publications detailing the rich institutional history of the House, in particular ‘‘The House’’, 

a critically acclaimed and long overdue history of the 

House; 


hsrobinson on DSK69SOYB1PROD with BILLS
2 

•HRES 1659 IH 

Whereas Robert V. Remini has assisted in the House’s commemoration of events of historical significance and in the 

development of exhibitions and educational programs on 

the history of the House of Representatives and the 

United States Capitol; 

Whereas Robert V. Remini has upheld the high standards 

and traditions of the House with abiding devotion, and 

has performed his House duties in an impartial and professional manner; and 

Whereas Robert V. Remini has earned the respect, affection, 

and esteem of the United States House of Representatives: Now, therefore, be it 

1 Resolved, That, effective October 1, 2010, as a token 

2 of the appreciation of the House of Representatives for 

3 his long and faithful service, Robert V. Remini is hereby 

4 designated as Historian Emeritus of the United States 

5 House of Representatives. 

Æ 


hsrobinson on DSK69SOYB1PROD with BILLS